149 related articles for article (PubMed ID: 10843222)
1. Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton.
Sou S; Mayumi S; Takahashi H; Yamasaki R; Kadoya S; Sodeoka M; Hashimoto Y
Bioorg Med Chem Lett; 2000 May; 10(10):1081-4. PubMed ID: 10843222
[TBL] [Abstract][Full Text] [Related]
2. Alpha-glucosidase inhibitors with a phthalimide skeleton: structure-activity relationship study.
Takahashi H; Sou S; Yamasaki R; Sodeoka M; Hashimoto Y
Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1494-9. PubMed ID: 11045457
[TBL] [Abstract][Full Text] [Related]
3. Alpha-glucosidase inhibitors with a 4,5,6,7-tetrachlorophthalimide skeleton pendanted with a cycloalkyl or dicarba-closo-dodecaborane group.
Sou S; Takahashi H; Yamasaki R; Kagechika H; Endo Y; Hashimoto Y
Chem Pharm Bull (Tokyo); 2001 Jun; 49(6):791-3. PubMed ID: 11411542
[TBL] [Abstract][Full Text] [Related]
4. New N-(phenoxydecyl)phthalimide derivatives displaying potent inhibition activity towards alpha-glucosidase.
Pascale R; Carocci A; Catalano A; Lentini G; Spagnoletta A; Cavalluzzi MM; De Santis F; De Palma A; Scalera V; Franchini C
Bioorg Med Chem; 2010 Aug; 18(16):5903-14. PubMed ID: 20667739
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of restriction enzymes EcoRI, BamHI and HindIII by phenethylphenylphthalimides derived from thalidomide.
Motoshima K; Ishikawa M; Hashimoto Y; Sugita K
Chem Pharm Bull (Tokyo); 2011; 59(7):880-4. PubMed ID: 21720041
[TBL] [Abstract][Full Text] [Related]
6. Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase.
Zhang Y; Gao H; Liu R; Liu J; Chen L; Li X; Zhao L; Wang W; Li B
Bioorg Med Chem Lett; 2017 Sep; 27(18):4309-4313. PubMed ID: 28838691
[TBL] [Abstract][Full Text] [Related]
7. Potent α-glucosidase inhibitors from safflower (Carthamus tinctorius L.) seed.
Takahashi T; Miyazawa M
Phytother Res; 2012 May; 26(5):722-6. PubMed ID: 22021176
[TBL] [Abstract][Full Text] [Related]
8. Enzymic synthesis of alpha- and beta-D-glucosides of 1-deoxynojirimycin and their glycosidase inhibitory activities.
Asano N; Oseki K; Kaneko E; Matsui K
Carbohydr Res; 1994 May; 258():255-66. PubMed ID: 8039179
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of α-glucosidase activity by N-deoxynojirimycin analogs in several insect phloem sap feeders.
Ya'kobovitz MK; Butters TD; Cohen E
Insect Sci; 2016 Feb; 23(1):59-67. PubMed ID: 25900765
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of N-phenylphthalimide derivatives as alpha-glucosidase inhibitors.
Pluempanupat W; Adisakwattana S; Yibchok-Anun S; Chavasiri W
Arch Pharm Res; 2007 Dec; 30(12):1501-6. PubMed ID: 18254235
[TBL] [Abstract][Full Text] [Related]
11. Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists.
Motoshima K; Ishikawa M; Sugita K; Hashimoto Y
Biol Pharm Bull; 2009 Sep; 32(9):1618-20. PubMed ID: 19721243
[TBL] [Abstract][Full Text] [Related]
12. Binding residues and catalytic domain of soluble Saccharomyces cerevisiae processing alpha-glucosidase I.
Faridmoayer A; Scaman CH
Glycobiology; 2005 Dec; 15(12):1341-8. PubMed ID: 16014748
[TBL] [Abstract][Full Text] [Related]
13. Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related α-glucosidase inhibitors and liver X receptor antagonists.
Motoshima K; Sugita K; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2011 May; 21(10):3041-5. PubMed ID: 21478015
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
Rawlings AJ; Lomas H; Pilling AW; Lee MJ; Alonzi DS; Rountree JS; Jenkinson SF; Fleet GW; Dwek RA; Jones JH; Butters TD
Chembiochem; 2009 Apr; 10(6):1101-5. PubMed ID: 19294724
[TBL] [Abstract][Full Text] [Related]
15. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Bis-indolylmethane sulfonohydrazides derivatives as potent α-Glucosidase inhibitors.
Gollapalli M; Taha M; Ullah H; Nawaz M; AlMuqarrabun LMR; Rahim F; Qureshi F; Mosaddik A; Ahmat N; Khan KM
Bioorg Chem; 2018 Oct; 80():112-120. PubMed ID: 29894890
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of novel, conjugated, fluorescent DNJ derivatives for α-glucosidase recognition.
Hatano A; Kanno Y; Kondo Y; Sunaga Y; Umezawa H; Okada M; Yamada H; Iwaki R; Kato A; Fukui K
Bioorg Med Chem; 2017 Jan; 25(2):773-778. PubMed ID: 27956035
[TBL] [Abstract][Full Text] [Related]
18. Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRalpha-selective antagonists.
Motoshima K; Noguchi-Yachide T; Sugita K; Hashimoto Y; Ishikawa M
Bioorg Med Chem; 2009 Jul; 17(14):5001-14. PubMed ID: 19539483
[TBL] [Abstract][Full Text] [Related]
19. Design and screening strategies for alpha-glucosidase inhibitors based on enzymological information.
Hakamata W; Kurihara M; Okuda H; Nishio T; Oku T
Curr Top Med Chem; 2009; 9(1):3-12. PubMed ID: 19199993
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis of L-Iminofuranoses and Their Biological Evaluations].
Natori Y
Yakugaku Zasshi; 2021; 141(1):15-24. PubMed ID: 33390442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
